课题基金基金详情
Aurora B激酶在动脉粥样硬化中的作用和机制研究
结题报告
批准号:
31960201
项目类别:
地区科学基金项目
资助金额:
38.0 万元
负责人:
甘滔
依托单位:
学科分类:
蛋白质、多肽与酶生物化学
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
甘滔
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
动脉粥样硬化是全球死亡率最高的疾病—心血管疾病的主要成因,最新研究成果表明细胞周期调控异常也是动脉粥样硬化的促进因素之一。基于动脉粥样硬化病变部位的基因芯片数据提示细胞周期调控分子AurkB激酶与动脉粥样硬化具有相关性,而我们的前期数据也表明动脉粥样硬化模型鼠中AurkB基因的表达显著升高。因此,我们推测AurkB基因可参与动脉粥样硬化病变的调控。在本课题中,我们将对以下科学问题进行研究:1.进一步明确AurkB在动脉粥样硬化病变中的表达和定位情况;2.研究AurkB表达升高是否对动脉粥样硬化有促进作用;3.探究AurkB调控动脉粥样硬化的可能分子机制。通过回答这些问题,我们将了解AurkB基因在动脉粥样硬化中的潜在作用及其调控病变过程的分子机制,并有可能为动脉粥样硬化的临床研究提供新的靶点。
英文摘要
Atherosclerosis (AS) is the primary cause of cardiovascular disease, which has the highest death rate worldwide. Recent research data indicate that cell cycle dysregulation could be a stimulating event for AS development. Gene profiling data based on AS plagues has indentified one cell-cycle regulator AurkB to be positively associated with this disease. Our preliminary data also proved that AurkB expression was significantly upregulated in the AS mouse model. Therefore, we hypothesize that AurkB is involved in the regulation of atherosclerosis. In this proposal, we will investigate the following scientific questions:1. to further determine the expression changes and localization of AurkB using various tissues from AS mice; 2. to examine whether increased level of AurkB can facilitate the development of AS; 3. to clarify the molecular mechanism employed by AurkB to regulate AS . The answers to these question will help us to understand the potential role played by AurkB in AS development, and might provide a potential drug target for AS clinical research.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10. 3969/j. issn. 1001 -5779. 2023. 04. 004
发表时间:2023
期刊:赣南医学院学报
影响因子:--
作者:张峰华;张顺美;朱奕帆;甘滔
通讯作者:甘滔
DOI:10.1016/j.gene.2022.146576
发表时间:2022-05-16
期刊:GENE
影响因子:3.5
作者:Ding, Suping;Gan, Tao;Yuan, Zhidong
通讯作者:Yuan, Zhidong
国内基金
海外基金